Accra, July 22, GNA - The Food and Drugs Board (FDB), on Wednesday said that the coartem tablets on the market "are mere dummy tablets with no anti-malaria activity and hence of no benefit to patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback